Interestingly, transcriptional upregulation of DYRK2 inhibits survival and self-renewal of CML stem/progenitor cells via c-Myc depletion and p53 activation (72). The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.